Protara Therapeutics, Inc.TARANASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-32.99%
↑ 39% above average
Average (9y)
-54.26%
Historical baseline
Range
High:-6.96%
Low:-176.52%
CAGR
+18.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -32.99% | +81.3% |
| 2023 | -176.52% | -100.4% |
| 2022 | -88.07% | -90.3% |
| 2021 | -46.29% | -233.8% |
| 2020 | -13.87% | +41.0% |
| 2019 | -23.51% | -134.0% |
| 2018 | -10.04% | +85.3% |
| 2017 | -68.21% | +10.4% |
| 2016 | -76.14% | -994.5% |
| 2015 | -6.96% | - |